{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:04:14Z","timestamp":1770501854262,"version":"3.49.0"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1093\/jac\/44.2.283","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:24:55Z","timestamp":1027722295000},"page":"283-286","source":"Crossref","is-referenced-by-count":42,"title":["In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp."],"prefix":"10.1093","volume":"44","author":[{"given":"Gema","family":"Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"Monz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan L.","family":"Rodr\u00edguez-Tudela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,8]]},"reference":[{"key":"key\n\t\t\t\t20170411034433_R1","doi-asserted-by":"crossref","unstructured":"Edwards, J. E., Bodley, G. P., Bowden, R. A., Buchner, T., DePauw, B. E., Filler, S. G. et al.(1997). International conference for the development of a consensus on the management and prevention of severe candidal infections. Clinical Infectious Diseases25, 43\u201359.","DOI":"10.1086\/514504"},{"key":"key\n\t\t\t\t20170411034433_R2","unstructured":"Bartroli, J., Turmo, E., Alguer\u00f3, M., Boncompte, M., Vericat, L., Conte, L., Ramis, J. et al. (1997). UR-9825: A new triazole derivative with potent broad-spectrum antifungal activity. In Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract E-67, p. 125. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411034433_R3","doi-asserted-by":"crossref","unstructured":"Bartroli, J., Turmo, E., Alguer\u00f3, M., Boncompte, E., Vericat, M. L., Conte, L. et al. (1998). New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. Journal of Medical Chemistry41, 1869\u201382.","DOI":"10.1021\/jm9707277"},{"key":"key\n\t\t\t\t20170411034433_R4","unstructured":"Vericat, M. L., Alguer\u00f3, M., Merlos, M., P\u00e9rez, L. L., Ara\u00f1o, A. & Forn, J. (1997). UR-9825, a novel broad spectrum triazole for treatment of fungal infections: oral activity in systemic mycoses. In Final Programme and Abstract Book Trends in Invasive Fungal Infections 4., Barcelona, Spain, 1997.>Abstract P-94, p. 142. Imedex, The Netherlands."},{"key":"key\n\t\t\t\t20170411034433_R5","unstructured":"National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS, Villanova, PA."},{"key":"key\n\t\t\t\t20170411034433_R6","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Tudela, J. L. & Mart\u00ednez-Su\u00e1rez, J. V. (1994). Improved medium for fluconazole susceptibility testing of Candida albicans.Antimicrobial Agents and Chemotherapy38, 45\u20138.","DOI":"10.1128\/AAC.38.1.45"},{"key":"key\n\t\t\t\t20170411034433_R7","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Tudela, J. L., Mart\u00ednez-Su\u00e1rez, J. V., Dronda, F., Laguna, F., Chaves, F. & Valencia, E. (1995). Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. Journal of Antimicrobial Chemotherapy35, 793\u2013804.","DOI":"10.1093\/jac\/35.6.793"},{"key":"key\n\t\t\t\t20170411034433_R8","doi-asserted-by":"crossref","unstructured":"Barry, A. L. & Brown, S. D. (1996). In-vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species. Antimicrobial Agents and Chemotherapy40, 1948\u20139.","DOI":"10.1128\/AAC.40.8.1948"},{"key":"key\n\t\t\t\t20170411034433_R9","doi-asserted-by":"crossref","unstructured":"McGinnis, M. R., Pasarell, L., Sutton, D. A., Fothergill, A. W., Cooper, C. R. & Rinaldi, M. G. (1997). In-vitro evaluation of voriconazole against some clinically important fungi. Antimicrobial Agents and Chemotherapy41, 1832\u20134.","DOI":"10.1128\/AAC.41.8.1832"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/44\/2\/283\/13057120\/JAC442283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:24:00Z","timestamp":1583310240000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/44.2.283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":9,"journal-issue":{"issue":"2","published-online":{"date-parts":[[1999,8]]},"published-print":{"date-parts":[[1999,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/44.2.283","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}